New York, USA - December 24, 2024 - "Bringing together a lively community of antibody engineering experts and innovators," a delegate from Creative Biolabs says, "this is one of the most prestigious antibody-related events we've ever been engaged in."
The topics that have received considerable attention in recent times, including bispecifics, ADCs, protein degraders, and immuno-oncology, have once again attracted a willing audience of scientists, researchers, and professionals in biotechnology, among whom Creative Biolabs made a significant impact at Booth #620, where they were interacting with a constant flow of visitors looking to discuss the latest in antibody engineering and therapeutics.
Their team of accomplished scientists presented one-of-a-kind suites of services for antibody development projects, represented by custom antibody engineering services that stand out for precision and innovation.
Visitors showed particular interest in:
Antibody Conversion
Industry-leading antibody conversion solutions whereby therapeutic antibodies are converted into various species or formats to meet specific therapeutic, diagnostic, or research needs, with their performance uncompromised and functionality improved, like half-life.
* Antibody Isotype Conversion
* Antibody Species Conversion
* Fc Engineering
* ScFv/Fab Fragment Engineering
* Glycoengineering
* ADC Conversion
* Antibody-to-CAR Conversion
* PEGylation & Chemical Conjugation
* Antibody Reformatting for Delivery Systems
Using proprietary technologies, Creative Biolabs now optimizes antibody binding strength to maximize therapeutic efficacy—a critical step in developing next-generation antibody drugs.
* Untargeted Mutagenesis
* Oligonucleotide-Directed Mutagenesis
* Phage Display Antibody Library Screening
* Antibody Affinity Measurement
* Peptide Affinity Maturation
Antibody Stability Improvement
Stability is a prerequisite to therapeutic success. The delegates introduced how they utilize advanced computational modeling and experimental validation to increase antibody stability and support long-term performance in diversified conditions, like scFv/Fab screening on thermal stability.
From academia to industry thought leaders, drop-by visitors also stopped by to dive into the hottest topics related to neurodegenerative disease therapies, challenges of the tumor microenvironment, and antibody immune agonists. The booth was always abuzz with energy, reflecting the growing excitement around emerging biotechnologies and solutions to pressing technical hurdles.
In view of the future, Creative Biolabs is excited for its presence at upcoming events that will further their relationship with the scientific community.
"We would like to thank everyone who stopped by booth 620 and took part in the enriching discussions that defined this year's conference." The delegate says. "Please save the dates for our presence at the Scientist Solution Vendor Event at Johns Hopkins on March 13, 2025, and the NIH Spring Research Vendor Fair on April 9, 2025. We are very much looking forward to continuing these fruitful discussions and to the discovery of new possibilities of jointly moving antibody therapeutics forward."
Web: https://www.creative-biolabs.com
About
Creative Biolabs' comprehensive suite of services is designed to accelerate antibody development projects with end-to-end solutions that stand out for their precision and innovation.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com
